Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00679302 · ClinicalTrials.gov registry record · Phase 4
Utility of Trimethoprim-sulfamethoxazole Use in Skin Abscess Management
A Phase 4 study, sponsored by St. Louis University.
- Completed
- Registry status
- Phase 4
- Development phase
- 161
- Enrollment target
NCT00679302 is a Phase 4 study that has completed, run by St. Louis University. The registered enrollment target is 161 participants.
The verdict
NCT00679302, a Phase 4 study, has completed, sponsored by St. Louis University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 161 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if antibiotics are required in the management of skin abscess following incision and drainage.
Interventions
- DRUG Trimethoprim-sulfamethoxazole
- DRUG Placebo group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 161 participants |
| Start Date | 2006-07 |
| Est. Completion | 2008-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00679302
The ClinicalTrials.gov registry entry for NCT00679302 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 161 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Louis University, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Trimethoprim-sulfamethoxazole is the first listed.
NCT00679302 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00679302 about?
NCT00679302 is a clinical study titled "Utility of Trimethoprim-sulfamethoxazole Use in Skin Abscess Management". The purpose of this study is to determine if antibiotics are required in the management of skin abscess following incision and drainage.
What is the current status of trial NCT00679302?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 161 participants. The study started on 2006-07. Estimated completion is 2008-05.
What interventions are being tested in trial NCT00679302?
The interventions under investigation include: Trimethoprim-sulfamethoxazole (DRUG), Placebo group (DRUG).
Who is sponsoring clinical trial NCT00679302?
This trial is sponsored by St. Louis University, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.